First Gene Editing Therapy Among Seven Drugs On Track For EU-Wide Approval
CHMP Confirms Non-Renewal Of Conditional Authorization For GSK’s Multiple Myeloma Drug
The European Medicines Agency has recommended seven new drugs for EU-wide approval, and OKd two others under its EU-M4all procedure that is meant for high-priority human medicines intended for markets outside the EU.
